Description
PF-2341066 inhibits the enzymatic activity of the c-Met tyrosine kinase, the receptor of hepatocyte growth factor/scatter factor (HGF/SF), interfering with pathways leading to cell growth and metastasis. It targets ALK (Karpas299 cells) and c-Met (A549, MDA-MB-231, GTL-16, HT29, 786-O, Colo-205, A498 cells).